Acceptance and Commitment Therapy (ACT) for Combating the Effects of Race-Related Stress Among Black Adolescents

November 3, 2023 updated by: Xzania Lee, Children's Hospital Los Angeles

The Healing Power of Acceptance: Evaluating the Efficacy of Acceptance and Commitment Therapy (ACT) in Combating the Effects of Race-Related Stress Among Black Adolescents

The current study seeks to build on previous research that demonstrates the efficacy of Acceptance and Commitment Therapy in combating stigma by investigating the feasibility and acceptability of a protocol to support Black adolescents and young adults in coping with race related stress. The study will consist of a small, purposeful, non-randomized sample (N = 30) of clients enrolled into a 10-session Acceptance and Commitment Therapy group. The group will be offered as part of regular clinical care at the Division of Adolescent and Young Adult Medicine. Three consecutive groups will be run with approximately 8-10 participants in each group over the next year.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • California
      • Los Angeles, California, United States, 90027
        • Recruiting
        • Children's Hospital Los Angeles
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 21 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Identify as Black/African American
  • English-speaking

Exclusion Criteria:

  • Prisoners or youth in detention centers will be excluded.
  • Not capable of participating meaningfully in the assent/consent process.
  • Being at significant risk for suicide and self-injury
  • Currently experiencing psychosis
  • Having severe health concerns that will impact study participation or attendance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Acceptance Commitment Therapy
This study will use a 10-session ACT protocol to support Black adolescents and young adults in coping with race related stress.
This intervention will be guided by: Payne, J. S. (2022). Out of the Fire: Healing Black Trauma Caused by Systemic Racism Using Acceptance and commitment Therapy New Harbinger Publications, Inc.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total Score on Index of Race-Related Stress (IRRS)-Brief Version
Time Frame: 12 weeks
Higher scores on this measure indicate greater race-related stress. The minimum score on this measure is 0 and the maximum is 88.
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total Scores on Acceptance and Action Questionnaire-2
Time Frame: 12 weeks
Higher scores on this measure indicate greater psychological flexibility. The minimum score on this measure is 7 and the maximum is 49.
12 weeks
Total Scores on Multidimensional Inventory of Black Identity-Teen (MIBI-t)
Time Frame: 12 weeks
Higher scores on this measure indicate stronger racial identity. The minimum score on this measure is 21 and the maximum is 105.
12 weeks
Total Score on Patient Health Questionaire-9
Time Frame: 12 weeks
Higher scores indicate greater depression. The minimum score on this measure is 0 and the maximum is 27.
12 weeks
Total Score on General Anxiety Disorder-7
Time Frame: 12 weeks
Higher scores indicate greater anxiety. The minimum score on this measure is 0 and the maximum is 21.
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Xzania Lee, PhD, Children's Hospital Los Angeles

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 28, 2023

Primary Completion (Estimated)

July 31, 2024

Study Completion (Estimated)

July 31, 2024

Study Registration Dates

First Submitted

January 5, 2023

First Submitted That Met QC Criteria

January 5, 2023

First Posted (Actual)

January 17, 2023

Study Record Updates

Last Update Posted (Actual)

November 7, 2023

Last Update Submitted That Met QC Criteria

November 3, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on ACT for Race Related Stress

3
Subscribe